AC
MIRO

Aristides Capital’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Aristides Capital’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,500
Closed -$122K – 191
2021
Q2 		$122K Buy
+10,500
New +$135K 0.03% 137

Other funds holding MIRO

GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Aristides Capital's MIRO Position: Q3 2021 in Review

Aristides Capital sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2021, closing a stake of 10,500 shares — an estimated $122K sold.

Aristides Capital first reported a position in MIRO in Q2 2021 and held it in 1 quarter. The position peaked at $122K in Q2 2021. 19 funds tracked by Wall St. Rank hold MIRO as of Q3 2021.

  • Aristides Capital reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Aristides Capital sold 10,500 Miromatrix Medical Inc. Common Stock shares in Q3 2021, an estimated $122K.
  • Aristides Capital first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Aristides Capital's Miromatrix Medical Inc. Common Stock position peaked at $122K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2021.

Based on Aristides Capital's 13F filing for Q3 2021, filed 12 Nov 2021.